Boris Quednow

Boris B. Quednow, Prof. Dr. rer. nat.

Interim Department Chair
Coordinator Center for Psychatric Research
Group Leader

Phone: +41 (0)58 384 27 77

E-Mail

Curriculum vitae

Boris B. Quednow studied psychology at the University of Bonn and obtained his PhD in neuroscience from Ruhr University Bochum. During his postdoc he worked at the Department of Psychiatry of the University of Bonn and at the University Hospital of Psychiatry Zurich. Currently, he is Full Professor of Experimental Pharmacopsychology and Psychological Addiction Research at the Department of Adult Psychiatry, University Hospital of Psychiatry Zurich, University of Zurich. His research focuses on understanding the neurochemical and genetic mechanisms underlying alterations in social and non-social cognition and decision-making associated with recreational substance use and substance use disorders.

Complete Publication List

ORCID: https://orcid.org/0000-0001-7933-2865

Publications in ZORA:

ZORA Publication List

Publications

Rodríguez-Ruiz, J., Zych, I., Ribeaud, D., Steinhoff, A., Eisner, M., Quednow, B. B., & Shanahan, L. (2024). The Influence of Different Dimensions of the Parent–Child Relationship in Childhood as Longitudinal Predictors of Substance Use in Late Adolescence. The Mediating Role of Self-Control International Journal of Mental Health and Addiction, 22, 3073–3090. https://doi.org/10.1007/s11469-023-01036-8
Jungwirth, J., Bavato, F., & Quednow, B. B. (2024). Psychedelika und Dissoziativa in der Psychiatrie: Herausforderungen in der Behandlung Der Nervenarzt, 95, 803–810. https://doi.org/10.1007/s00115-024-01727-0
Kroll, S. L., Meier, P., Mayo, L. M., Gertsch, J., & Quednow, B. B. (2024). Endocannabinoids and related lipids linked to social exclusion in individuals with chronic non-medical prescription opioid use Neuropsychopharmacology, 49, 1630–1639. https://doi.org/10.1038/s41386-024-01881-8
Bavato, F., Barro, C., Schnider, L. K., Simrén, J., Zetterberg, H., Seifritz, E., & Quednow, B. B. (2024). Introducing neurofilament light chain measure in psychiatry: current evidence, opportunities, and pitfalls Molecular Psychiatry, 29, 2543–2559. https://doi.org/10.1038/s41380-024-02524-6
Rabl, M., Zullo, L., Lewczuk, P., Kornhuber, J., Karikari, T. K., Blennow, K., Zetterberg, H., Bavato, F., Quednow, B. B., Seifritz, E., von Gunten, A., Clark, C., & Popp, J. (2024). Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression Alzheimer’s Research & Therapy, 16, 165. https://doi.org/10.1186/s13195-024-01526-4
Steinhoff, A., Bechtiger, L., Birchler, K., Ribeaud, D., Eisner, M., Quednow, B. B., & Shanahan, L. (2024). Cannabis Use from Early Adolescence to the Mid-Twenties in Children of Immigrant and Nonimmigrant Parents: Findings from a Prospective Longitudinal Cohort Study International Journal of Mental Health and Addiction, 1–22. https://doi.org/10.1007/s11469-024-01359-0
Johnson-Ferguson, L., Shanahan, L., Loher, M., Bechtiger, L., Binz, T. M., Baumgartner, M. R., Ribeaud, D., Eisner, M., & Quednow, B. B. (2024). Higher paracetamol levels are associated with elevated glucocorticoid concentrations in hair: findings from a large cohort of young adults Archives of Toxicology, 98, 2261–2268. https://doi.org/10.1007/s00204-024-03747-w
Zacher, A., Zimmermann, J., Cole, D. M., Friedli, N., Opitz, A., Baumgartner, M. R., Steuer, A. E., Verdejo-Garcia, A., Stock, A.-K., Beste, C., & Quednow, B. B. (2024). Chemical cousins with contrasting behavioural profiles: MDMA users and methamphetamine users differ in social-cognitive functions and aggression European Neuropsychopharmacology, 83, 43–54. https://doi.org/10.1016/j.euroneuro.2024.04.010
Opitz, A., Zimmermann, J., Cole, D. M., Coray, R. C., Zachäi, A., Baumgartner, M. R., Steuer, A. E., Pilhatsch, M., Quednow, B. B., Beste, C., & Stock, A.-K. (2024). Conflict monitoring and emotional processing in 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine users – A comparative neurophysiological study NeuroImage. Clinical, 41, 103579. https://doi.org/10.1016/j.nicl.2024.103579
Bavato, F., Seifritz, E., & Quednow, B. B. (2024). The multifaceted role of neurofilament light chain protein: emerging opportunities in primary psychiatric conditions Brain : A Journal of Neurology, 147, e5–e6. https://doi.org/10.1093/brain/awad281
Eggenberger, L., Janousch, C., Loher, M., Ribeaud, D., & Quednow, B. B. (2024). Substanzkonsum junger Menschen in der Schweiz: Verbreitung, Entwicklungen und Auswirkungen SuchtMagazin, 28–35.
Johnson-Ferguson, L., Shanahan, L., Bechtiger, L., Steinhoff, A., Zimmermann, J., Baumgartner, M. R., Binz, T. M., Eisner, M., Ribeaud, D., & Quednow, B. B. (2023). Associations of psychoactive substances and steroid hormones in hair: Findings relevant to stress research from a large cohort of young adults Psychoneuroendocrinology, 157, 106369. https://doi.org/10.1016/j.psyneuen.2023.106369
Kroll, S. L., Hulka, L. M., Kexel, A.-K., Vonmoos, M., Preller, K. H., Treyer, V., Ametamey, S. M., Baumgartner, M. R., Boost, C., Pahlisch, F., Rohleder, C., Leweke, F. M., & Quednow, B. B. (2023). Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density Translational Psychiatry, 13, 325. https://doi.org/10.1038/s41398-023-02628-7
Coray, R. C., Zimmermann, J., Haugg, A., Baumgartner, M. R., Steuer, A. E., Seifritz, E., Stock, A., Beste, C., Cole, D. M., & Quednow, B. B. (2023). The functional connectome of 3,4‐methyldioxymethamphetamine‐related declarative memory impairments Human Brain Mapping, 44, 5079–5094. https://doi.org/10.1002/hbm.26438
Egger, K., Gudmundsen, F., Jessen, N. S., Baun, C., Poetzsch, S. N., Shalgunov, V., Herth, M. M., Quednow, B. B., Martin-Soelch, C., Dornbierer, D., Scheidegger, M., Cumming, P., & Palner, M. (2023). A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine Frontiers in Pharmacology, 14, 1140656. https://doi.org/10.3389/fphar.2023.1140656
Vock, F., Johnson-Ferguson, L., Bechtiger, L., Stulz, N., von Felten, J., Eisner, M., Hepp, U., Ribeaud, D., Shanahan, L., & Quednow, B. B. (2023). Substance use in sexual minority youth: prevalence in an urban cohort Child and Adolescent Psychiatry and Mental Health, 17, 109. https://doi.org/10.1186/s13034-023-00657-0
Sidorenko, N., Chung, H.-K., Grueschow, M., Quednow, B. B., Hayward-Könnecke, H., Jetter, A., & Tobler, P. N. (2023). Acetylcholine and noradrenaline enhance foraging optimality in humans Proceedings of the National Academy of Sciences of the United States of America, 120, 2305596120. https://doi.org/10.1073/pnas.2305596120
Coray, R. C., Berberat, J., Zimmermann, J., Seifritz, E., Stock, A.-K., Beste, C., Cole, D. M., Unschuld, P. G., & Quednow, B. B. (2023). Striatal Iron Deposition in Recreational MDMA (Ecstasy) Users Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 8, 956–966. https://doi.org/10.1016/j.bpsc.2023.02.005
Stock, A.-K., Werner, A., Kuntke, P., Petasch, M.-S., Bensmann, W., Zink, N., Koyun, A. H., Quednow, B. B., & Beste, C. (2023). Gamma-Aminobutyric Acid and Glutamate Concentrations in the Striatum and Anterior Cingulate Cortex Not Found to Be Associated with Cognitive Flexibility Brain Sciences, 13, 1192. https://doi.org/10.3390/brainsci13081192
Dornbierer, D. A., Zölch, N., Baur, D. M., Hock, A., Stucky, B., Quednow, B. B., Kraemer, T., Seifritz, E., Bosch, O. G., & Landolt, H. (2023). Nocturnal sodium oxybate increases the anterior cingulate cortex magnetic resonance glutamate signal upon awakening Journal of Sleep Research, 32, e13866. https://doi.org/10.1111/jsr.13866

Quicklinks

Main navigation